OBI — Ondine Biomedical Balance Sheet
0.000.00%
- £41.00m
- £40.53m
- CA$1.20m
Annual balance sheet for Ondine Biomedical, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2009 December 31st | 2010 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | CAS | CAS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 1.06 | 0.877 | 30.4 | 13.1 | 2.98 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.153 | 0.257 | 0.248 | 0.182 | 0.326 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1.56 | 1.64 | 33.5 | 15.1 | 4.75 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.451 | 0.484 | 0.601 | 1.4 | 0.949 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 2.62 | 2.53 | 34.1 | 16.6 | 5.73 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.28 | 2.11 | 3.92 | 3.91 | 3.49 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.34 | 2.25 | 4.48 | 4.92 | 3.65 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 1.28 | 0.279 | 29.7 | 11.6 | 2.08 |
Total Liabilities & Shareholders' Equity | 2.62 | 2.53 | 34.1 | 16.6 | 5.73 |
Total Common Shares Outstanding |